Rapt Therapeutics, Inc. (RAPT)
58.02
0.00 (0.00%)
USD |
NASDAQ |
Mar 06, 16:00
Rapt Therapeutics SG&A Expense (TTM) : 29.76M for Sept. 30, 2025
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Penumbra, Inc. | 663.42M |
| Amicus Therapeutics, Inc. | 383.49M |
| Disc Medicine, Inc. | 65.38M |
| Amylyx Pharmaceuticals, Inc. | 62.89M |
| Johnson & Johnson | 23.68B |